Company newsCompany release
SELLAS Life Sciences Group closes public offering for $172.5 million gross
The offering included the full exercise of the underwriters' option to buy 1,730,769 additional shares at $13.00 per share.
GetSignal
SELLAS Life Sciences Group said on November 20, 2026 that it closed its underwritten public offering of 13,269,231 shares of common stock at a public offering price of $13.00 per share.
Aggregate gross proceeds were $172.5 million, before underwriting discounts, commissions and offering expenses. Investors in the offering included new healthcare-focused institutional investors.
Key facts
- Shares sold
- 13,269,231 shares of common stock
- Public offering price
- $13.00 per share
- Gross proceeds
- $172.5 million before underwriting discounts, commissions and offering expenses
Source: The company's release on GlobeNewswire, November 20, 2026.
Written by GetSignal with AI from the company's press release. How we make news
Not investment advice.
More company news
SELLAS Life Sciences Group first, then the newest- SELLAS Life Sciences Group prices 11,538,462-share offering at $13.00 per share
SLS · SELLAS Life Sciences Group · Form 8-K and release · Nov 17, 2026
- SELLAS says Phase 3 REGAL trial of galinpepimut-S met its primary endpoint in AML
SLS · SELLAS Life Sciences Group · Form 8-K and release · Nov 17, 2026
- Western Digital stockholders elect nine directors at annual meeting
WDC · Western Digital · Form 8-K · Nov 20, 2026
- Ares Capital subsidiary amends BNP Paribas funding facility
ARCC · Ares Capital · Form 8-K · Nov 20, 2026
